Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.56 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.54 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | ABL1 | P00519 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30512021 | 1.00 | HSD17B10 (1.00) | HSD17B10MEN1KMT2APTGS1AKR1C3 | |
| Hydrochloric Acid SCHEMBL2527402 | 0.98 | HSD17B10 (0.97) | HSD17B10MEN1KMT2APTGS1AKR1C3 | |
| SCHEMBL28778581 | 0.91 | HSD17B10 (0.82) | HSD17B10MEN1KMT2APTGS1AKR1C3 | |
| SCHEMBL17967503 | 0.87 | HSD17B10 (0.77) | HSD17B10MEN1KMT2APTGS1AKR1C3 | |
| SCHEMBL30831943 | 0.86 | HSD17B10 (0.75) | HSD17B10MEN1KMT2APTGS1AKR1C3 | |
| SCHEMBL5743959 | 0.86 | HSD17B10 (0.75) | HSD17B10MEN1KMT2AIDO1ADRA1A | |
| SCHEMBL1097902 | 0.86 | HSD17B10 (0.75) | HSD17B10MEN1KMT2APTGS1AKR1C3 | |
| SCHEMBL7418168 | 0.85 | HSD17B10 (0.74) | HSD17B10MEN1KMT2APTGS1AKR1C3 | |
| SCHEMBL17764790 | 0.84 | HSD17B10 (0.72) | HSD17B10MEN1KMT2AGAA | |
| Hydrochloric Acid SCHEMBL2527027 | 0.84 | HSD17B10 (0.73) | HSD17B10MEN1KMT2APTGS1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112174800-B | Preparation method of 2, 5-dimethoxy phenylacetic acid | 爱斯特（成都）生物制药股份有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-112321413-A | Preparation method of 2, 5-dimethoxy phenylacetic acid | 爱斯特（成都）生物制药股份有限公司 | 2021-02-05 | — | — | CN | claimed |
| CN-112321412-A | Preparation method of 2, 5-dimethoxy phenylacetic acid | 爱斯特（成都）生物制药股份有限公司 | 2021-02-05 | — | — | CN | claimed |
| CN-112239402-A | Preparation method of 2, 5-dimethoxy phenylacetic acid | 爱斯特（成都）生物制药股份有限公司 | 2021-01-19 | — | — | CN | claimed |
| CN-112174800-A | Preparation method of 2, 5-dimethoxy phenylacetic acid | 爱斯特（成都）生物制药股份有限公司 | 2021-01-05 | — | — | CN | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-6398857-B1 | ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS | XEROX CORPORATION | 2002-06-04 | — | — | US | claimed |
| WO-2023170024-A1 | CAMK2 MODULATORS AND THEIR USE IN MEDICINE | UNIVERSITY OF COPENHAGEN (DK) | 2023-09-14 | — | — | WO | disclosed |
| CN-112174800-B | Preparation method of 2, 5-dimethoxy phenylacetic acid | 爱斯特（成都）生物制药股份有限公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-112174800-B | Preparation method of 2, 5-dimethoxy phenylacetic acid | 爱斯特（成都）生物制药股份有限公司 | 2023-07-28 | — | — | CN | disclosed |
| EP-0116444-A2 | Improvements in or relating to benzazepine derivatives | ELI LILLY AND COMPANY (US) | 1984-08-22 | — | — | EP | disclosed |
| US-4247597-A | Electroscopic carrier particles having a carboxylic acid surface treatment | PITNEY BOWES, INC. (US) | 1981-01-27 | — | — | US | disclosed |
| US-4182720-A | Process for the preparation of homogentisic lactone | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | HSD17B10 2219/4885MEN1 685/4885KMT2A 1624/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | HSD17B10 2365/4885MEN1 1466/4885KMT2A 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.